HOME >> BIOLOGY >> NEWS
Findings could aid efforts to harness nature for making drugs

WEST LAFAYETTE, Ind. - Chemical engineers at Purdue University have shown how to make yeast cells double the activity and boost productivity of a type of enzyme plants need to create important chemicals such as anticancer compounds.

The work is related to efforts aimed at developing techniques to use plants and microorganisms as natural factories for producing pharmaceuticals. Such techniques would be safer and more environmentally friendly than conventional methods for making drugs, which often require hazardous chemicals and steel "reactors" operated at high pressures and temperatures. The enzymes from plants and other organisms typically function in water near room temperature under ordinary pressure.

The Purdue researchers demonstrated that altering the nutrients and carefully controlling fermentation time caused yeast cultures to produce an enzyme called ferulate 5-hydroxylase that has twice its normal rate of activity, which increases the enzyme's productivity.

"Activity relates to the amount of product that can be synthesized in a given time," said John Morgan, an assistant professor of chemical engineering at Purdue. "So we could make more than twice the amount of product per hour."

Findings are detailed in a paper appearing in the Jan. 20 issue of the journal Biotechnology and Bioengineering, published by John Wiley & Sons Inc. The paper was written by Morgan and Purdue doctoral student Hanxiao Jiang.

The enzyme is a member of a family of enzymes called cytochrome P450, which plants need to produce numerous chemical compounds.

Plants ordinarily produce small quantities of "flavonoids," which are beneficial chemicals known as antioxidants. So researchers are developing ways to boost production of the chemicals by transferring vital enzymes from plants to microorganisms. Because P450 enzymes are "biocatalysts" that enable an organism to produce the beneficial drugs, researchers are trying to develop techniques t
'"/>

Contact: Emil Venere
venere@purdue.edu
765-494-4709
Purdue University
28-Jan-2004


Page: 1 2 3

Related biology news :

1. Findings suggest need for new view of p53 cancer proteins interaction with DNA
2. Findings redefine mechanism of action of RNA helicase enzymes
3. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
4. Findings offer clue to how molecule can both stimulate, suppress cell growth
5. Findings offer further understanding about growth and development in young male gymnasts
6. Findings in frog oocytes may help study of chromosome physiology
7. Findings aid understanding of neurodegenerative diseases
8. Findings show exceptional longevity runs in families
9. Findings give insight into how colon cells transform into precancerous polyps
10. Findings conclude sustained caffeine intake negates the benefits of creatine supplements
11. Findings link disease specific anitbodies to activation of T cells for the first time

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 24, 2020 , ... ... of chronic inflammatory and fibrotic diseases, today announced that Dr. Stacie Canan has ... Discovery. , Dr. Canan previously served as Executive Director of Global Health at ...
(Date:8/26/2020)... HOUSTON (PRWEB) , ... August 25, 2020 , ... ... it made Inc. magazine’s 2020 annual Inc. 5000 list. The list is the most ... list in 2019 as well, and for this year’s list, reported three-year revenue growth ...
(Date:8/21/2020)... ... August 19, 2020 , ... “How can ... businesses dedicated to Salivary Bioscience for more than twenty years. Together with Douglas ... Springer, " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications ," and ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 12, 2020 , ... ... International), a global leader in FDA compliance consulting has been named on its ... companies. The list represents a unique look at the most successful companies within ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now ... With 50 million stem cells total, patients may choose which extremities they would like ... arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained ...
(Date:7/31/2020)... and SOMERSET, N.J (PRWEB) , ... July 29, ... ... genome editing company, and Catalent, the leading global provider of advanced delivery technologies, ... health products, today announced that they have entered into a strategic partnership whereby ...
(Date:7/22/2020)... , ... July 22, 2020 , ... Join experts from ... Lorenc, Sr. Manager Regulatory Solutions, in a one hour live webinar on ... regulating body in China for drugs and medical devices. Specifically, for medical devices, the ...
Breaking Biology Technology:
Cached News: